Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation—A preliminary report-Reference-Cited by-同舟云学术

Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation—A preliminary report

Published:1997-04 Issue:4 Volume:32 Page:531-535
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Nagaya Masahiro,Futamura Masahide,Kato Junji,Niimi Norihiro,Fukuta Sumio

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference23 articles.

1. Extracorporeal membrane oxygenation (ECMO), cardiopulmonary support in infancy;Bartlett;Trans ASAIO,1976

2. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure, 100 cases;Bartlett;Ann Surg,1986

3. Extracorporeal membrane oxygenation and neonatal respiratory failure: Experience from the extracorporeal life support;Stolar;J Pediatr Surg,1991

4. National experience with extracorporeal membrane oxygenation for newborn respiratory failure;Toomasian;ASAIO,1988

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulant Medications: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference;Pediatric Critical Care Medicine;2024-07

2. Current and future strategies to monitor and manage coagulation in ECMO patients;Thrombosis Journal;2023-01-26

3. Anticoagulation with nafamostat mesilate during extracorporeal life support;International Journal of Cardiology;2022-11

4. Hemostasis in Pediatric Extracorporeal Life Support;Pediatric Clinics of North America;2022-06

5. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review;Artificial Organs;2022-05-09